The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK MIDDAY BRIEFING: Royal Dutch Shell Taps New Chairman, Lifts Profit

Thu, 30th Oct 2014 12:44

LONDON (Alliance News) - Royal Dutch Shell, the largest London-listed stock by market capitalisation, headlined a busy and mostly positive day of UK company earnings Thursday. But the updates were unable to counteract macro-economic uncertainties driving the overall market lower.

The oil major reported a rise third-quarter earnings, as weak oil prices were offset by higher-margin production and improved earnings from gas, while also announcing the replacement of its long-serving chairman, Jorma Ollila.

Shell said earnings on a current cost of supplies basis totalled USD5.3 billion in the quarter ended September 30, compared to USD4.2 billion in the third quarter of 2013. Revenue totalled USD107.85 billion, down from the second quarter when it totalled USD111.22 billion, mainly due to weak oil prices. Revenue also was down compared to a year earlier, when it generated USD116.51 billion.

Jefferies says Royal Dutch Shell's "very strong" third quarter results have "soundly beaten" its estimates and now believes the stock can eventually start trading at a premium to its peers.

Shell also said it has appointed Charles Holliday as chairman with immediate effect. Holliday will replace Ollila, who has held the role for nine years. Holliday was appointed as a non-executive director of Shell in 2010, and has previously been the chairman of DuPont and of Bank of America.

Despite its positive update, Shell 'A' shares were down 1.6% at midday, quoted at 2,200.00 pence, undermined by renewed weakness in crude oil prices.

Instead it was St James's Place that was topping the FTSE 100 after the morning session. The wealth manager reported strong growth in funds under management in the third quarter, buoyed by a 23% increase in net inflows as clients took the opportunity of the higher limits now allowed on the amount that can be put into Individual Savings Accounts.

The company said its funds under management stood at GBP49.1 billion at the end of September, up from GBP41.8 billion a year earlier and up 11% since the start of 2014, as it booked net inflows of GBP1.27 billion in the quarter, up from GBP1.03 billion a year earlier.

St James's Place shares were up 2.5% at 705.50p.
----------
Markets: UK stock indices have given up early strength to trade lower by midday as the optimism provided by some strong corporate earnings ahead of the open faded into wider concerns over the health of the global economy, after the Federal Reserve ended its stimulus program on Wednesday.

US stock futures are pointing to a weak start for Wall Street, with the DJIA set to open down 0.1%, the S&P 500 down 0.5%, and Nasdaq Composite 0.6% lower, improving slightly following the release of third-quarter GDP figures.

FTSE 100: down 0.8% at 6,400.34
FTSE 250: down 0.3% at 15,196.07
AIM ALL-SHARE: down 0.2% at 713.53
GBP-USD: down at 1.5983
EUR-USD: down at 1.2584
GOLD: down at USD1,200.75 an ounce
OIL (Brent): down at USD86.31 a barrel
---------
Other Top UK Corporate News
----------
Barclays said it has set aside GBP500 million in light of regulators' investigations into alleged foreign exchange manipulation, as the British lender beat analyst forecasts with the level of its rise in third-quarter adjusted pretax profit. Barclays also announced an extra GBP170 million provision for the payment of payment protection insurance claims, but this was offset by a GBP160 million release of provision for interest rate hedging redress. It said it made a GBP1.22 billion pretax profit in the third quarter of 2014, compared with GBP1.17 billion in the corresponding quarter last year. On an adjusted basis, which strips out items such as the foreign exchange provision, own credit, and gains and losses on acquisitions and disposals, Barclays' third-quarter pretax profit increased to GBP1.59 billion from GBP1.39 billion.
----------
Barclays, HSBC Holdings and Royal Bank of Scotland Group will make a total provision of about GBP1 billion for settlements with regulators following a probe into the abuse of foreign exchange benchmarks, Sky News reported on Wednesday. Sky News said it understands the banks plan to make the provision as part of their third-quarter results.
----------
BT Group raised its interim dividend by 15%, after reporting growth in profits, buoyed by growth in BT Sport subscribers and its fibre broadband operations and due to cost cutting. The company reported a pretax profit of GBP1.11 billion for the six months to September 30, up from GBP948 million a year earlier, even though revenue declined to GBP8.74 billion, from GBP8.94 billion. Its pretax profit in the fiscal second quarter rose to GBP690 million, from GBP609 million a year earlier, even though revenue fell to GBP4.38 billion, from GBP4.49 billion. Chief Executive Gavin Patterson said the results were slightly ahead of market expectations, driven by reduced costs and higher operating earnings.
----------
US federal and state prosecutors have reopened investigations into Standard Chartered to determine whether the bank withheld evidence of Iran sanctions violations, Bloomberg reported on Thursday, citing two people briefed on the matter. The US Justice Department, Manhattan District Attorney Cyrus Vance Jr and New York Department of Financial Service Superintendent Benjamin Lawsky are all reopening their inquiries into the bank to determine if it deliberately withheld information from regulators prior to the 2012 deferred prosecution agreement, Bloomberg added.
----------
AstraZeneca said the US Food and Drug Administration has approved its once-daily XIGDUO XR drug for the treatment of adults with type 2 diabetes. XIGDUO XR is already approved in Australia for the treatment of adults with type 2 diabetes, along with diet and exercise. XIGDUO, meanwhile, is approved in the European Union.
----------
Aviva reported an 12% rise in value of new business from continuing operations, driven by increases across Europe and Asia more than offsetting a drop in the UK and Ireland. The insurer's value of new business from continuing operations in the first nine months of the year rose to GBP690 million from GBP619 million in the corresponding period last year.
----------
Kazakhmys reported increases in sales volumes during the first nine months of the year and stated it is on target to hit full-year production guidance. During the third quarter ended September 30, the company extracted 9,520 kilotonnes of ore compared to 9,351 kilotonnes in the second quarter. A year earlier, the company produced 9,984 kilotonnes of ore. Kazakhmys saw the copper grade decrease, averaging 0.97% in the third quarter compared to 1.01% in the previous quarter. A year earlier it averaged a copper grade of 1.00%.
----------
Henderson Group said its assets under management increased in the third quarter, with net inflows boosted by its UK and European retail businesses and global institutional flows. The FTSE 250 investment manager said assets under management increased 2.5% to GBP76.6 billion at September 30. That number was further boosted to GBP79.9 billion on October 1 following the completion of its acquisition of US equity manager Geneva Capital Management for GBP120 million. The group said it saw net inflows of GBP1.4 billion in the period, driven by the performance of its UK retail, European retail and global institutional performance.
----------
Transport operator National Express Group said its third-quarter pretax profit was up nearly 15% on the year, driven by revenue growth, performance improvements and cost cutting, and said it is on track to meet its profit and cash expectations for the year as a whole. In a statement, it said the growth meant it was progressively recovering the one-off hits and currency translation impact it suffered in the first half of the year. National Express said passenger numbers and revenue are up in all its divisions so far this year. Revenue was up 4% on the year in the three months to end-September in its UK bus unit and 3% in the year to date.
----------
Al Noor Hospitals Group said its revenue increased in the third quarter in line with its expectations and said it is on track to meet forecasts for the full year. The FTSE 250 company, which provides healthcare services in Abu Dhabi, said revenue in the three months to September 30 was up 20.5% to USD101.2 million from USD84 million a year earlier. Al Noor said the rise was in line with its expectations and said its earnings before income, taxation, depreciation and amortisation margins were stable in the period.
----------
Countrywide said its earnings and revenue both increased in the third quarter, though it said it was seeing an impact from the slowdown in the London market and sounded a note of caution on the possible challenges it may face in 2015. The FTSE 250 estate agency said revenue in the third quarter to the end of September was GBP188.4 million, up 22% year-on-year, with earnings before income, taxation, depreciation and amortisation at GBP40.2 million, up 38%.
----------
RPS Group said it will again increase its full-year dividend by 15%, after saying it is on track to report good growth for 2014 on a constant currency basis, while investments in its international platform are providing "significant" growth opportunities. In a statement, the energy and environmental consultancy did caution that currency volatility and the uncertainty affecting the oil and gas sector make it difficult to predict the full-year result with precision, but trading so far in 2014 suggests it is on track to achieve market expectations.
----------
Afren reported flat net profit for the first nine months of 2014 as a tax exemption credit offset a fall in pretax profit and revenue driven by lower production, and it said it is implementing the recommendations in a recent review of its business practices as it tries to put a recent payments scandal behind it. Afren reported a net profit of USD167.9 million for the nine months to September 30, compared with GBP170.1 million profit a year earlier, mainly thanks to a income tax credit of USD1.3 million as a result of now being in a five-year tax exemption period for the Ebok field in Nigeria and thanks to a smaller loss on derivative financial instruments of USD0.6 million, down from USD38.7 million.
----------
AIM Movers
----------
Ferrex shares are up 9.7% after it was given the environmental permit approval for the Nayega Manganese project in northern Togo, a key milestone in securing the mining permit for the site, which it expects to receive by the end of the year. The company has also received an extension on its prospecting permits after it relinquished half of the area. Nostra Terra Oil & Gas is also higher after it said production increased 80% in the third quarter compared with the second quarter, averaging 84 barrels of oil equivalent per day during September alone. Union Jack Oil and Egdon Resources are both down after Egdon said it would plug the Wolds-1 well in Leicestershire after finding weak hydrocarbon shows and thin, water-bearing sands.
----------
Top Economics And General
----------
US economic activity increased by more than expected in the third quarter of 2014, according to a report released by the Commerce Department. The Commerce Department said GDP increased by 3.5% in the third quarter compared to the 4.6% growth seen in the second quarter. Economists had expected GDP to climb by 3.0%. Meanwhile, initial jobless claims edged up to 287,000 in the week ended October 25.
----------
The US Federal Reserve voted Wednesday to end its monthly purchases of government-backed debt, citing "sufficient underlying strength in the broader economy" to halt the unconventional monetary stimulus programme. The central bank also kept its benchmark interest rate near zero, which it said "remains appropriate" - more than five years after the US escaped the 2007-09 recession. The unprecedented low Federal Funds rate, in place since December 2008, is likely to remain in place "for a considerable time," the Fed's monetary policy committee said, "especially if projected inflation continues to run below the committee's 2% longer-run goal."
----------
UK house prices rebound more than expected in October, survey figures from the Nationwide Building Society showed. The house price index recovered by 0.5% from September, when it fell 0.1% for the first time after sixteen consecutive months of rising. Economists were looking for a 0.3% increase. Year-on-year, house prices rose 9%, after an 9.4% gain in the previous month. Economists had forecast a 8.5% climb in prices. The unadjusted average house price rose to GBP189,333 in October from GBP188,374 in September.
----------
Germany's jobless rate remained unchanged in September, provisional results from the Federal Statistical Office showed. The unemployment rate held steady at adjusted 5% in September. In the same period of 2013, the rate was 5.2%. On an unadjusted basis, the jobless rate fell marginally to 4.9% from 5% in August.
----------
China's current account surplus grew in the third quarter from the previous three months, figures from the State Administration of Foreign Exchange (SAFE) showed. The current account surplus rose to USD81.5 billion from USD73.4 billion in the second quarter. The capital and financial account deficit, meanwhile, widened to USD81.6 billion from USD16.2 billion in the previous three months.
----------
EU-brokered efforts to resolve a gas dispute between Russia and Ukraine were due to resume late Thursday, Russian Energy Minister Alexander Novak told local media, after talks in Brussels the previous night failed to deliver a breakthrough. Russia has not sold gas to Ukraine since June due to a row over billions of dollars in arrears. The EU is concerned that the showdown will disrupt gas supplies across the continent, where the energy-intensive winter is approaching. A sticking point in the talks late Wednesday had been Kiev's inability to provide a written guarantee for its next upfront gas payments, as demanded by Moscow, Novak told Russian media.
----------
An Israeli counter-terrorism unit shot dead a Palestinian man suspected of trying to kill a far-right Jewish activist. Officers surrounded the suspect's house in the East Jerusalem neighbourhood of Abu Tur and opened fire when the Palestinian suspect shot at them, spokesman Micky Rosenfeld said. Quds Brigades, the armed wing of the radical Islamic Jihad faction, identified him as Mutaz Hijazi, 32, one of its members. It said Hijazi had served 11 years in Israeli jails and was released in 2012.
----------
The party of Ukrainian President Petro Poroshenko claimed victory Wednesday in parliamentary elections held at the weekend, while the pro-Russian separatists in the country's east said they were preparing for war.
----------
Afternoon Watchlist (all times GMT)

13:00 Germany Consumer Price Index Preliminary
13:00 US Fed's Yellen Speech
14:30 US EIA Natural Gas Storage
---------
Friday's Key UK Corporate Events

International Consolidated Airlines Group - Q3 Results
1Spatial - Half Year Results
Elementis - Interim Management Statement
Berendsen - Interim Management Statement
Direct Line Insurance Group - Interim Management Statement
Royal Bank of Scotland Group - Interim Management Statement
Asia Resource Minerals - Interim Management Statement
Regus Group - Interim Management Statement
WPP - Trading Statement
---------
Friday's Key Economic Events (all times GMT)

00:05 UK Gfk Consumer Confidence
n/a Japan BoJ Monetary Policy Statement
05:00 Japan Housing Starts/Construction Orders
06:00 Japan BoJ outlook report
n/a Japan BoJ Press Conference
07:00 Germany Retail Sales
07:45 France Consumer Spending and Producer Prices
09:00 Italy Consumer Price Index
09:00 Italy Unemployment
10:00 EU Consumer Price Index
10:00 EU Unemployment Rate
11:00 Italy Producer Price Index
12:30 US Employment cost index
12:30 US Personal Income/Spending
14:45 US Chicago Purchasing Managers' Index
14:55 US Reuters/Michigan Consumer Sentiment Index
---------
Contact: +44 203 668 7440; newsroom@alliancenews.com; @AllNewsTeam

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.